What is the Share Price of Dr Lal Pathlabs Ltd?

Dr Lal Pathlabs Ltd share price is ₹3,505.95 As on 12 October, 2024|06:13

Home
>
Stocks
>
Dr Lal Pathlabs Ltd

Dr Lal Pathlabs Ltd

Q: What is the Market Cap of Dr Lal Pathlabs Ltd?

The Market Cap of Dr Lal Pathlabs Ltd is ₹29,301 As on 12 October, 2024|06:13

Q: What is PE Ratio of Dr Lal Pathlabs Ltd?

The P/E ratio of Dr Lal Pathlabs Ltd is 76.8 As on 12 October, 2024|06:13

Q: What is PB Ratio of Dr Lal Pathlabs Ltd?

The PB ratio of Dr Lal Pathlabs Ltd is 15.79 As on 12 October, 2024|06:13

₹ 3,505.95 -22.90 (-0.65%)
Updated on 11-10-2024 6:23 PM

Stock Rating

Pros 5

Cons 1

Option Chain

Price Performance

Day's Low
₹3,490.65

Day's High
₹3,543.45

₹ 3,505.95

52-w low
₹1,943.70

52-w high
₹3,653.95

3,505.95

Day's open
₹3,528.85
Previous close
₹3,528.85
VWAP
₹3,510.96
Lower price band
₹3,176
Upper price band
₹3,881.70

Today's Market Action

The last traded share price of Dr Lal Pathlabs Ltd was 3,505.95 down by -0.65% on the NSE. Its last traded stock price on BSE was 3,512.50 down by -0.40%. The total volume of shares on NSE and BSE combined was 79,586 shares. Its total combined turnover was Rs 27.94 crores.

Medium and Long Term Market Action

Dr Lal Pathlabs Ltd hit a 52-week high of 3,653.95 on 10-10-2024 and a 52-week low of 1,943.70 on 19-03-2024. The stock price of Dr Lal Pathlabs Ltd is up by 3% over the last one month. It is up by 40.28% over the last one year. Don't forget to check the full stock price history in the table below.

Fundamentals

Market Cap (Cr): 29301
Book Value (₹):
Stock P/E:
Revenue (Cr):
Total Debt (Cr):

Face Value (₹):
Roce (%):
ROE (%):
Earnings (Cr):
Promoter’s Holdings (%):

EPS (₹):
Debt to Equity:
Dividend Yield (%):
Cash (Cr):

Mutual fund holdings and trends

FUND NAME	Quantity	Monthly Change (Qty)

Shareholding Pattern

Similar Stocks

Company	Price	Market Cap (Cr)	P/E

About

Data not available.

FAQ's

What is Share Price of Dr Lal Pathlabs Ltd?

What is the Market Cap of Dr Lal Pathlabs Ltd?

What is PE Ratio of Dr Lal Pathlabs Ltd?

What is PB Ratio of Dr Lal Pathlabs Ltd?

What is the CAGR of Dr Lal Pathlabs Ltd?

How to Buy Dr Lal Pathlabs Ltd Share?

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Cash Flow)

Standalone Financial Performace In Graph(Cash Flow)

Pros

Momentum Strength
The stock is currently exhibiting strong momentum, & is showing consistent strong relative strength.
Above Average Sustainable RoE
The company generates a sustainable return on equity greater than the expected cost of capital which implies that the underlying business can create and compound value over a period time due to it's ability to generate above average return on capital.
Great Cash Conversion of Profits
The business has a great cash conversion ratio since it is able to convert a signifant portion of operating earnings of 78.91% into operating cash flow. This implies a great working capital cycle and large cash flows for either funding growth or dividends. This shall positively impact shareholder returns.
High Pricing Power
The business enjoys a relatively high pricing power and is able to withstand competitive pressure which works as a great moat for equity shareholders of the company.
Strong Working Capital Cycle
The company has a great working capital cycle of 19 days which results in lower investments in working capital and higher asset turnover. This reduces capital requirement of the business and drives RoE and cash flow generation positively. This is extremely positive for long term shareholders of the business.

Cons

Capital Intensive Business
The company operates an extremely capital intensive business with a low Asset turnover ratio of 1.76. A low asset turnover ratio negatively impacts RoE and reduces shareholder returns. Also due to the capital intensive nature of business, growth of the business would need to be funded either via increasing borrowings or diluting shareholders, both of which shall negatively impact shareholder value and returns.

Valuation Analysis

Margin of safety
(12/10/2024)

Margin of Safety Index: High

70.00%

70.00% People are bullish about Dr Lal Pathlabs Ltd

30.00%

30.00 % People are bearish about Dr Lal Pathlabs Ltd

What is your opinion about this Stock?

Historical Data

Date	Open	High	Low	Close	Volume	Daily Change %